IDEX (IEX) Q4 2025 Earnings Call Transcript
IDEX (IEX) reported solid Q4 2025 results, driven by strong performance in its Health & Science Technologies (HST) segment, particularly due to demand from data centers and semiconductors. The company achieved 1% organic revenue growth and expanded its adjusted EBITDA margin by 40 basis points. For 2026, IDEX anticipates 1%-2% organic growth, an adjusted EBITDA margin of 26%-27%, and adjusted EPS of $8.15-$8.35, while maintaining commitments to capital allocation including dividends and share repurchases.
https://www.theglobeandmail.com/investing/markets/markets-news/Motley%20Fool/23416/idex-iex-q4-2025-earnings-call-transcript/